StephenJShidelerMD

Dermatology • Sarasota, FL

Physician

Join to view full profile

Dr. Shideler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shideler's full profile

Already have an account?

Office
6600 University Pkwy
Sarasota, FL 34240
Phone+1 941-800-5001

Fax+1 941-800-5012

Education & Training

Indiana University School of MedicineResidency, Dermatology, 1976 - 1979
Indiana University School of MedicineInternship, Internal Medicine, 1974 - 1975
Indiana University School of MedicineClass of 1974

Certifications & Licensure

FL State Medical License 2019 - 2025
IN State Medical License 1974 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

VPD-737 for Treatment of Chronic Pruritus Start of enrollment: 2013 Oct 15
Completed
Phase 2
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis Start of enrollment: 2014 May 01
Completed
Phase 4
Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2014 Apr 01
Completed
Phase 2
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities Start of enrollment: 2014 May 01
Completed
Phase 3
Twelve Month Follow-Up of CP0108 Start of enrollment: 2014 Aug 01
Completed
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01
Completed
Phase 2
Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
Join now to see all

Press Mentions

Topical Glycopyrronium Tosylate (DRM04) for the Treatment of Primary Axillary Hyperhidrosis: Pooled Results from the ATMOS-1 and ATMOS-2 Phase 3 Randomized Controlled TrialsAugust 2nd, 2018
Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisAugust 2nd, 2018

Professional Memberships

American Academy of Dermatology - AAD
Fellow